Literature DB >> 9278873

Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.

R S Beanlands1, T D Ruddy, L Bielawski, H Johansen.   

Abstract

BACKGROUND: Current clinical approaches may not always be helpful in the early differentiation of necrotic tissue from ischemic viable myocardium in patients with acute myocardial infarction. Tc-99m-glucaric acid is a carbohydrate ligand that may permit differentiation of necrosis from ischemia. However, the myocardial kinetics of Tc-99m-glucaric acid have not been well defined early after myocardial injury. The aim of this study was to evaluate the effect of necrosis in comparison to postischemic injury alone on the kinetics of Tc-99m-glucaric acid with the use of an isolated perfused rat heart model. METHODS AND
RESULTS: Three groups of hearts were studied: group I: control (n = 6); group II: postischemia (15 minutes of no flow with complete reperfusion, n = 6); and group III: necrosis (90 minutes of no flow to induce necrosis with complete reperfusion, n = 6). Tc-99m-glucaric acid (1.3 +/- 0.6 mCi/L of buffer) was perfused for 30 minutes to evaluate tracer accumulation. Then tracer-free buffer was perfused for 45 minutes to evaluate clearance. The peak accumulation relative to the control group mean was significantly increased (p < 0.01) in group III (necrosis) (254% +/- 75%) compared with control (100% +/- 10%) and compared with postischemia (108% +/- 26%). On kinetic data analysis, the monoexponential clearance rate constant: (kc) was significantly reduced with necrosis (control: kc = 20.2 +/- 14.0 x 10(-4) sec-1; postischemia: kc = 22.3 +/- 15.2 x 10(-4) sec-1; and necrosis: kc = 1.2 +/- 0.3 x 10(-4) sec-1; p < 0.05). A retention fraction was calculated from the activity after 45 minutes of clearance corrected for the peak activity for each group. The necrotic group had significant myocardial retention in comparison to control and postischemia (control: 12% +/- 8%; postischemia: 14% +/- 16%; necrosis: 64% +/- 10%; p < 0.01).
CONCLUSIONS: The accumulation and retention of Tc-99m-glucaric acid is markedly increased in the presence of myocardial necrosis in comparison to control and postischemic myocardial injury. In this model, Tc-99m-glucaric acid is capable of defining the presence of necrotic myocardial injury in comparison to postischemic injury alone. This agent may have potential application for the early differentiation of ischemic from necrotic myocardium in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278873     DOI: 10.1016/s1071-3581(97)90104-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  18 in total

1.  Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?

Authors:  R S Beanlands; F Dawood; W H Wen; P R McLaughlin; J Butany; G D'Amati; P P Liu
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

2.  Localization of technetium-99m-glucarate in zones of acute cerebral injury.

Authors:  H Yaoita; T Uehara; A L Brownell; C A Rabito; M Ahmad; B A Khaw; A J Fischman; H W Strauss
Journal:  J Nucl Med       Date:  1991-02       Impact factor: 10.057

3.  Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.

Authors:  R S Beanlands; R A DeKemp; E Harmsen; J P Veinot; N G Hartman; T D Ruddy
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

4.  Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs.

Authors:  J T Lie; P C Pairolero; K E Holley; J L Titus
Journal:  J Thorac Cardiovasc Surg       Date:  1975-04       Impact factor: 5.209

5.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

6.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

Authors:  M C Fishbein; S Meerbaum; J Rit; U Lando; K Kanmatsuse; J C Mercier; E Corday; W Ganz
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

7.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

8.  Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab.

Authors:  B A Khaw; T Yasuda; H K Gold; R C Leinbach; J A Johns; M Kanke; M Barlai-Kovach; H W Strauss; E Haber
Journal:  J Nucl Med       Date:  1987-11       Impact factor: 10.057

9.  Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats.

Authors:  H Ohtani; R J Callahan; B A Khaw; A J Fishman; R A Wilkinson; H W Strauss
Journal:  J Nucl Med       Date:  1992-11       Impact factor: 10.057

10.  Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid.

Authors:  C Orlandi; P D Crane; D S Edwards; S H Platts; L Bernard; J Lazewatsky; M J Thoolen
Journal:  J Nucl Med       Date:  1991-02       Impact factor: 10.057

View more
  8 in total

1.  99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.

Authors:  David R Okada; Zhonglin Liu; Gerald Johnson; Delia Beju; Ban An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-24       Impact factor: 9.236

2.  Technetium 99m glucarate: what will be its clinical role?

Authors:  M C Gerson; A J McGoron
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

3.  Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia.

Authors:  D R Okada; G Johnson; Z Liu; S D Hocherman; B A Khaw; K Y Pak; R D Okada
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

4.  Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand.

Authors:  L L Johnson; L Schofield; P Mastrofrancesco; T Donahay; A Farb; B A Khaw
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

5.  (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.

Authors:  Gerald Johnson; Christine C Okada; Sonia D Hocherman; Zhonglin Liu; Curtis Hart; Ban-An Khaw; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-20       Impact factor: 9.236

6.  High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion.

Authors:  Zhonglin Liu; Harrison H Barrett; Gail D Stevenson; George A Kastis; Michael Bettan; Lars R Furenlid; Donald W Wilson; Koon Yan Pak
Journal:  J Nucl Med       Date:  2004-07       Impact factor: 10.057

Review 7.  Non-invasive in vivo imaging of myocardial apoptosis and necrosis.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-14       Impact factor: 9.236

Review 8.  Untiring Pursuit for Glucarate-Based Molecular Imaging Probes.

Authors:  Dongjian Zhang; Qiaomei Jin; Meng Gao; Cuihua Jiang; Yicheng Ni; Jian Zhang
Journal:  Mol Imaging Biol       Date:  2020-11-18       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.